NAVB Oldtimers Lounge - InvestorVillage
This is a semi-private group. You are free to browse messages, but you must be a member of this group to post messages. Join This Group

Group: NAVB Oldtimers Lounge   /  Message Board

 
 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous 36 Messages Top of Message List
Go to Msg #  
MSG # SUBJECT TYPE AUTHOR SENTIMENT RECS DATE POSTED
13746 EBITDA/Sales covenants in CRG loan. Annually $5 mm ebitda-$11mm sales from LS in 2015 with sales target moving to $45 mm in 2020. PM must also cover any negative ebitda GN moneyonomics 0 5/21/2015 5:14:50 PM
13745 Re: Book by Siamon Gordon "The Macrophage as Therapeutic Target"-including difficulties, etc fyi asking price for this book at site is appox $650 GN moneyonomics 0 5/21/2015 2:47:13 PM
13744 Book by Siamon Gordon "The Macrophage as Therapeutic Target"-including difficulties, etc GN moneyonomics 0 5/20/2015 10:42:36 PM
13743 Was the update targeting of Cd80/86 macrophage activation in diabetes ignored by anyone--recall targeting table? GN moneyonomics 0 5/20/2015 10:00:52 PM
13742 Update on targeting of Cd80/86 in macrophage activation (signal 2 for t cell activation) with therapeutics to possibly prevent Type 1 diabetes GN moneyonomics 1 5/20/2015 1:00:43 AM
13741 Correction: Would a 15+ year old investment firm that exploits market inefficiencies, led by chemical engineers, mathematicians and electrical engineers; buy into NAVB, if NAVB did not have strong upside potential? TFS Capital did for .576 mm shares! GN moneyonomics 0 5/18/2015 7:42:19 PM
13740 Would Goldman raise their share investment by 3.123 mm shares, UBS by .944 mm shares and Vanguard by .303 mm shares for a long term low potential stock? GN moneyonomics 0 5/18/2015 6:55:38 PM
13739 Would a 25+ year old investment firm that exploits market inefficiencies, led by chemical engineers, mathematicians and electrical engineers; buy into NAVB, if NAVB did not have strong upside potential? TFS Capital did for .576 mm shares! GN moneyonomics 0 5/18/2015 6:53:08 PM
13737 As of 3-31-2015 Institutional Ownership still around 33% even after PM 3.1 mm share sale which in essence was offset by Goldman Sachs at 3.2 mm share entry GN moneyonomics 2 5/16/2015 3:32:58 PM
13736 Re: Dr. McGrath and his team tested HIV drug ("infamous" Q drug GLQ223-Tricohsanthin) 26 years ago. Started FDA Phase 1/11 trials by Genelabs 1999; attacking macrophages. Could Manocept-Tilmanocept be the breakthrough delivery system to move forward? GN moneyonomics 0 5/15/2015 2:20:01 PM
Previous 36 Messages Top of Message List
Go to Msg #  


About Us    Contact Us    Follow Us on Twitter    Members Directory    Help    Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
2003-2015 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.

Loading...